Legal Framework for the Cultivation of Technical Cannabis for Medical Purposes
Regulatory pitfalls and licensing procedures
The cultivation of industrial hemp for medicinal purposes cannot be assessed solely based on THC content, as the intended use of the product is also a decisive factor. Once cannabis is intended for a therapeutic purpose, it falls under a strict licensing regime, and the grower needs permits from two authorities. The article explains the difference between industrial and medicinal cannabis, the requirements for a cultivation facility, and how to prepare for the licensing process.

Medicinal Cannabis vs. Industrial Hemp: The Key Difference That Decides Everything
Industrial hemp, whose content of the psychoactive substance THC must not exceed 1%, is subject to significantly milder rules. Its cultivation on an area of over 100 m² only requires notification to the relevant customs office. In contrast, cannabis for medicinal use is defined completely differently. The decisive factor is not its chemical composition, but the purpose for which it is intended.
As soon as a product is designated by the manufacturer "for therapeutic use in humans or for processing for this purpose," it falls under the strict regime of Act No. 167/1998 Coll., on Addictive Substances, and is considered an addictive substance. This triggers a complex and demanding licensing process.
This seemingly minor difference in definition has enormous practical implications. An entrepreneur can grow a plant with a low THC content that would chemically correspond to industrial hemp. However, if they market it with claims of medicinal effects, it automatically falls into the category of medicinal cannabis, and they risk penalties for handling addictive substances without the proper permits.
Our Prague-based lawyers at ARROWS will help you prepare a legal opinion that clearly determines which category your business plan falls into, thus protecting you from future disputes with administrative authorities.
Who and What Is Behind the Licensing Process?
The path to legally cultivating medicinal cannabis leads through two key institutions that act as market gatekeepers. Each applicant must successfully navigate two separate but interconnected proceedings to obtain:
1. A license to cultivate cannabis plants for medicinal use, issued by the State Institute for Drug Control (SÚKL).
2. A permit to handle addictive substances, granted by the Ministry of Health of the Czech Republic.
This dual structure means that it is necessary to simultaneously meet the requirements of two different authorities. While the SÚKL focuses on the technical, operational, and quality aspects of cultivation, the Ministry of Health grants the general authorization to handle a substance classified as a narcotic. Success with one authority does not automatically guarantee success with the other.
A crucial and often underestimated prerequisite is that the applicant must already have a fully functional and compliant cultivation facility at the time of submitting the application. This is not just a project on paper.
The application submitted to the SÚKL must include detailed technical documentation and photographic evidence of the existing and equipped facility. Before issuing the license, the SÚKL will conduct a physical on-site inspection to verify that reality matches the submitted documents.
This requirement represents a significant financial barrier to market entry. The costs of building a cultivation facility that meets strict security standards—from fencing with razor wire and camera systems connected to a central security desk to security doors—can run into millions of Czech crowns.
An entrepreneur must undertake this investment with the risk that the license may ultimately not be granted. This mechanism naturally favors entities with strong capital.
Representation before administrative authorities, such as the SÚKL and the Ministry of Health, is one of our key services. We ensure that communication with the authorities runs smoothly and that your application meets all the formal and substantive requirements of both institutions.
What Documents Are Essential for a Successful Application?
A license application is not just a form, but a comprehensive file that must demonstrate your complete readiness and professionalism. Any error or omission can lead to delays in the proceedings or rejection of the application. The SÚKL requires the submission of extensive documentation that maps out your entire future operation in detail.
Key documents include:
Identification details of the applicant and contact person.
Technical documentation describing the cultivation facility, equipment for cultivation, harvesting, processing, and especially a detailed description of the security system.
Photographic documentation of all relevant premises and equipment.
A very important internal regulation that details operational and security rules: who has access to the cultivation facility, under what conditions, and how plants and plant waste are handled.
Proof of payment of administrative fees and advances for expert services.
The quality and precision of these documents are the first signal to the SÚKL of your future operational capability. The authority logically assumes that an entity unable to prepare flawless documentation cannot be a reliable partner for cultivating and managing an addictive substance. A meticulously prepared application is therefore not just a bureaucratic necessity, but above all, a strategic investment in the credibility of your project.
Preparing documentation that protects against fines and penalties is our daily work. For clients from over 150 joint-stock companies and 250 limited liability companies (s.r.o.), we have prepared comprehensive documents for various licensing procedures. We will ensure your application is bulletproof.
Risks and Penalties | How ARROWS Helps |
Incomplete or incorrect license application: Delays the process by months, requires constant supplementation, or leads to rejection of the application and loss of investment. | We will prepare complete and flawless documentation in strict accordance with the Act on Addictive Substances and SÚKL requirements. |
Non-compliant cultivation facility security: Failure to meet Decree No. 235/2022 Coll. and a negative finding by SÚKL lead to license rejection. | We will provide consultations on technical requirements and review the project documentation from a legislative perspective. |
Inadequate internal regulations: Inability to demonstrate compliance with GACP and security protocols is a direct reason for application rejection. | We will draft tailor-made internal directives that comply with the law and actual operations. |
Inadequate personnel competence: Failure to meet the requirements for a responsible person (§ 9, § 19 of the Act on Addictive Substances) jeopardizes operations. | We will train management and key employees, issue certificates, and ensure compliance with qualification requirements. |
Problems during SÚKL inspection: Discovery of deficiencies directly in the cultivation facility causes delays or rejection of the licensing procedure. | We will thoroughly prepare you for the inspection and represent you in dealings with inspectors. |
Errors in corporate structure: An unclear ownership structure or incorrect applicant identification complicates the procedure. | We will review and adjust your structure to be fully transparent and compliant with the conditions for granting a license. |
Good Agricultural and Collection Practice (GACP): More Than Agriculture, Almost Pharmacy
The cultivation of medicinal cannabis is not governed by ordinary agricultural practices. The entire process must comply with the rules of Good Agricultural and Collection Practice (GACP), as defined by SÚKL guideline KLP-01 and implementing Decree No. 235/2022 Coll.. GACP represents a set of binding rules that elevate cultivation to a level approaching pharmaceutical production.
This standard requires the implementation of a robust quality management system that covers all aspects of operation: from qualified and vetted personnel and their regular training, through strict hygiene standards, to detailed requirements for premises and their security.
A key element of GACP is extremely detailed documentation and traceability. For each production batch (batch), you must keep precise records that allow every step to be traced back—from the origin of the mother plant, through the substrates and fertilizers used, to the exact conditions of harvesting and drying.
In practice, this means that GACP is primarily a data-driven system. It's not just about how you cultivate, but how you meticulously record every step. For the regulator, this data is proof that you are following the rules. For you as an entrepreneur, it is an invaluable tool for quality management, production optimization, and defense in case of any problems, such as batch contamination.
Our experts will not only prepare internal GACP guidelines for you but also conduct professional training for your employees and management. This ensures that your team will not only know the rules but also apply them correctly in practice, which is crucial for successful audits.
How to Avoid Penalties and Seize Opportunities?
Obtaining a license does not end your obligations—on the contrary, it marks the beginning of a phase of continuous demonstration of compliance. As a license holder, you will be under the constant supervision of the SÚKL and other authorities. Any violation of GACP rules, incorrect record-keeping, or security deficiencies can lead to significant penalties and, in the most extreme cases, revocation of the license, which would mean the loss of the entire investment.
At the same time, however, the amendment to the Act on Addictive Substances has brought about a fundamental liberalization of the market. Growers are no longer required to sell their production to the state. Now, under legally defined conditions, they can distribute medicinal cannabis directly to pharmacies, other distributors, or, crucially, export it abroad. This opens the door to lucrative European markets.
However, exporting brings another layer of legal complexity. Each country has its own, often different, regulations for importing medicinal cannabis. Successful export thus requires not only a perfect knowledge of Czech law but also of the legislation of the target country. It is here that the ability to navigate international law becomes a key competitive advantage.
Penalties and license revocation are existential threats to your investment. We provide ongoing legal consultations that protect you from risks and ensure continuous compliance with legislation.
Thanks to our ARROWS International network, built over ten years, we handle cases with an international element daily. We will help you prepare export contracts and ensure compliance with regulatory requirements in foreign markets.
Once you obtain your license and start operations, you face a new set of risks. This table identifies key threats in the operational phase and shows how ARROWS can help you ensure a long-term sustainable and secure business.
Your Path to Success in the Medicinal Cannabis Business Begins with ARROWS
Entering the medicinal cannabis cultivation industry is a marathon, not a sprint. It requires not only significant capital and operational excellence but, above all, a bulletproof legal strategy. As we have shown, from the initial concept to international expansion, entrepreneurs face a series of regulatory pitfalls where a single mistake can mean the end of the entire project.
At ARROWS, we understand not only law but also business. With our experience providing services to a portfolio of over 150 joint-stock companies, 250 limited liability companies (s.r.o.), and 51 municipalities and regions, we know how to set up processes efficiently and securely. We pride ourselves on speed and top-tier quality, which is essential in such a highly regulated industry.
Our team is ready to provide you with comprehensive support, whether you need:
obtaining a license and all necessary permits,
preparing complete documentation and internal guidelines (GACP),
representation before the SÚKL, the Ministry of Health, and other authorities,
reviewing or preparing contracts with suppliers and customers,
professional training for your team.
Moreover, we actively connect our clients when we see interesting business or investment synergies. We would be happy to hear about your business plan as well. Contact us today to arrange an initial consultation where we can discuss how we can ensure the success and security of your investment in the medicinal cannabis market.
About the author
Disclaimer:
The information contained in this article is for general informational purposes only and serves as a basic guide to the issue as of 2026. Although we strive for maximum accuracy, laws and their interpretation evolve over time. We are ARROWS Law Firm, a member of the Czech Bar Association (our supervisory authority), and for the maximum security of our clients, we are insured for professional liability with a limit of CZK 350,000,000. To verify the current wording of the regulations and their application to your specific situation, it is necessary to contact ARROWS Law Firm directly (consultation@arws.cz). We are not liable for any damages arising from the independent use of the information in this article without prior individual legal consultation.


